Ivonescimab
Drug timelines are a Plus or Pro feature.
71 regulatory and trial events tracked for Ivonescimab, covering 2024-07-08 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma [Phase 2]